Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

155
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
155
Depression: Overview01:18

Depression: Overview

238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

354
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
354
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

100
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
100
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

345
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
345
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

68
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Stimulant prescription for ADHD in people with a past history of anorexia nervosa.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026
Same author

Incidence of venous thromboembolism in women receiving transdermal oestradiol/testosterone with micronised progesterone in accordance with NICE guidelines.

Translational andrology and urology·2026
Same author

Use of transdermal testosterone to treat menopausal symptoms in women with a history of breast cancer: a small, retrospective, open-label study.

Menopause (New York, N.Y.)·2026
Same author

The primary care management of perimenopausal depression.

Australian journal of general practice·2026
Same author

Australia's first women's mental health hospital.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists·2026

Related Experiment Video

Updated: Jun 26, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Menopause depression: Under recognised and poorly treated.

Jayashri Kulkarni1, Caroline Gurvich1, Eveline Mu1

  • 1HER Centre Australia, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.

The Australian and New Zealand Journal of Psychiatry
|May 18, 2024
PubMed
Summary

Menopause significantly impacts mental health due to hormonal shifts, yet current treatments are inadequate. Innovative approaches prioritizing women's lived experiences are needed for better outcomes.

Keywords:
Menopausegonadal hormonesmenopause hormone therapy

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.5K
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.2K

Related Experiment Videos

Last Updated: Jun 26, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.5K
Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice
06:08

Evaluating the Anti-depression Effect of Xiaoyaosan on Chronically-stressed Mice

Published on: January 7, 2019

9.2K

Area of Science:

  • Reproductive Medicine
  • Neuroendocrinology
  • Mental Health

Background:

  • Menopause involves significant gonadal hormone shifts impacting mental well-being in many individuals.
  • Current management of menopause-related mental ill health often lacks specific focus on biological changes, leading to suboptimal outcomes.
  • This can result in premature workforce departure, financial loss, and diminished quality of life for affected women.

Purpose of the Study:

  • To highlight the inadequate understanding and management of mental ill health associated with menopause.
  • To advocate for innovative approaches that address the unique biological and psychological aspects of menopausal mental health.
  • To emphasize the critical role of women with lived experience in shaping these new strategies.

Main Methods:

  • A collaborative effort involving national and international clinicians, lived experience advocates, and social community representatives.
  • Review of current treatment paradigms for menopausal mental ill health.
  • Focus on integrating biological insights with patient-centered care.

Main Results:

  • Existing treatments for mental ill health during menopause are often generalized, failing to address specific hormonal influences.
  • Lack of specialized attention to brain-gonadal hormone changes contributes to poor treatment efficacy.
  • Women experience significant negative impacts on career, finances, relationships, and overall quality of life.

Conclusions:

  • There is a critical need to innovate the management of mental ill health during menopause.
  • Integrating biological understanding of hormonal shifts with patient-centered care is essential.
  • Centering the voices and experiences of women with menopause is paramount for developing effective and truly innovative solutions.